Shaheen Alanee, MD, MPH, MBA

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy	Endoscopic Surgical Procedure; High Risk Superficial Upper Urinary Tract Transitional Cell Carcinoma; Transitional Epithelial Cells	Not yet recruiting	Phase 2	2017-11-17		NCT03345134

Clinical trials